PofoliaShared via Pofolia

Journal of the American Geriatrics Society· 2014Q1· Review

Health Outcomes Associated with Polypharmacy in Community‐Dwelling Older Adults: A Systematic Review

Terri R. Fried, John R. O’Leary, Virginia Towle, Mary K. Goldstein et al.

Short summary

A systematic review of 50 studies found that polypharmacy (taking multiple prescribed medications) is associated with increased risks of falls, adverse drug events, hospitalization, and declines in function and cognition in community-dwelling older adults.

AI-generated from the title and abstract; the full text is not read.

Key points

  • Polypharmacy is associated with a range of adverse health outcomes in older adults.
  • Key negative outcomes include falls, adverse drug events, hospitalization, and functional/cognitive decline.
  • High-quality studies with good adjustment for comorbidity showed stronger associations.
  • Data are mixed, with some studies failing to demonstrate significant links.

AI-generated from the title and abstract; the full text is not read.

Abstract

OBJECTIVES: To summarize evidence regarding the health outcomes associated with polypharmacy, defined as number of prescribed medications, in older community-dwelling persons. DESIGN: Systematic review of MEDLINE (OvidSP 1946 to May, Week 3, 2014). SETTING: Community. PARTICIPANTS: Observational studies examining health outcomes according to number of prescription medications taken. MEASUREMENTS: Association between number of medications and health outcomes. Because of the importance of comorbidity as a potential confounder of the relationship between polypharmacy and health outcomes, articles were assessed regarding the quality of their adjustment for confounding. RESULTS: Of the 50 studies identified, the majority that were rated good in terms of their adjustment for comorbidity demonstrated relationships between polypharmacy and a range of outcomes, including falls, fall outcomes, fall risk factors, adverse drug events, hospitalization, mortality, and measures of function and cognition. However, a number of these studies failed to demonstrate associations, as did a substantial proportion of studies rated fair or poor. CONCLUSION: Data are mixed regarding the relationship between polypharmacy, considered in terms of number of medications, and adverse outcomes in community-dwelling older persons. Because of the challenge of confounding, randomized controlled trials of medication discontinuation may provide more-definitive evidence regarding this relationship than observational studies can provide.

The authors' abstract, as published at the source. Journal of the American Geriatrics Society, 2014 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Geriatrics and Gerontology

Geriatrics and GerontologyMedicine